Table 2.
The top three biofunction categories by GO analysis.
| Diseases and Disorders | p-value |
|---|---|
| Cancer | 7.25E -08–2.11E-03 |
| Inflammatory Response | 1.24E -06–1.91E-03 |
| Skeletal and Muscular Disorders | 1.39E -06–1.59E-03 |
| Connective Tissue Disorders | 2.25E -06–9.72E-04 |
| Inflammatory Disease | 2.25E -06–9.72E-04 |
| Molecular and Cellular Functions | p-value |
| Cell Death and Survival | 6.34E-16–2.06E-03 |
| Cell Cycle | 1.37E-15–2.07E-03 |
| Cellular Assembly and Organization | 3.34E-10–1.75E-03 |
| Cellular Function and Maintenance | 3.34E-10–2.01E-03 |
| Cellular Growth and Proliferation | 2.12E-09–2.15E-03 |
| Physiological System Development and Functions | p-value |
| Organism Survival | 5.93E-10–1.56E-03 |
| Embryonic Development | 5.86E-09–1.88E-03 |
| Organ Development | 5.86E-09–1.88E-03 |
| Organismal Development | 5.86E-09–1.96E-03 |
Shown are enrichment clusters of diseases such as cancer (p=ca. 10−8), and inflammation (p=ca. 10−6), molecular functions such as cell death and survival (p=ca. 10−16), and physiological processes such as organismal survival (p=ca. 10−10) and embryonic development (p=ca. 10−9).